Evidence for the Role of Membrane Receptor Lateral Movement in GTP-Binding Protein-Mediated Signal Transduction

  • David A. Jans
Part of the Molecular Biology Intelligence Unit book series (MBIU)


As we saw in the previous chapter, direct measurements indicate that plasma membrane polypeptide hormone receptors are mobile within the plane of the lipid bilayer. Tyrosine kinase and GTP-binding protein activating receptors appear to be essentially different in terms of their lateral mobility properties, and it seems plausible to relate these differences to their distinct signal transduction mechanisms.1–8 As discussed in chapter 4, lateral movement of hormone-occupied tyrosine kinase receptors is required to effect receptor dimerization which triggers the association of a variety of cytosolic signaling molecules in order to effect signal transduction.9–13 Movement of the hormone-occupied receptor is not required subsequent to dimerization, and consistent with this, activated receptors appear to be aggregated and essentially immobile at physiological temperature (see section E, chapter 4).


Adenylate Cyclase Adenylate Cyclase Activation Renal Epithelial Cell Mobile Fraction Lateral Mobility 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Jans DA. The mobile receptor hypothesis revisited: a mechanistic role for hormone receptor lateral mobility in signal transduction. Biochim Biophys Acta 1992; 1113: 271–276.PubMedCrossRefGoogle Scholar
  2. 2.
    Jans DA, Pavo I. A mechanistic role for polypeptide hormone receptor lateral mobility in signal transduction. Amino Acids 1995; 9: 93–109.Google Scholar
  3. 3.
    Jans DA, Peters R, Zsigo J et al. The adenylate cyclase-coupled vasopressin V2-receptor is highly laterally mobile in membranes of LLC-PK, renal epithelial cells at physiological temperature. EMBO. J 1989; 8 (9): 2431–2438.Google Scholar
  4. 4.
    Jans DA, Peters R, Fahrenholz F. Lateral mobility of the phospholipase-C-activating vasopressin V,-type receptor in A7r5 smooth muscle cells: a comparison with the adenylate cyclase-coupled V2-receptor. EMBO J 1990; 9 (9): 2693–2699.PubMedGoogle Scholar
  5. 5.
    Jans DA, Peters R, Jans P et al. Ammonium chloride affects receptor number and lateral mobility of the vasopressin V2-type receptor in the plasma membrane of LLC-PK, renal epithelial cells: role of the cytoskeleton. Exper Cell Res 1990; 191: 121–128.CrossRefGoogle Scholar
  6. 6.
    Jans DA, Peters R, Fahrenholz F. An inverse relationship between receptor internalization and the fraction of laterally mobile receptors for the vasopressin renal-type V2-receptor; an active role for receptor immobilization in down-regulation? FEBS Lett 1990; 274: 223–226.PubMedCrossRefGoogle Scholar
  7. 7.
    Jans DA, Peters R, Jans P et al. Vasopressin V2-receptor mobile fraction and ligand-dependent adenylate cyclase-activity are directly correlated in LLC-PK, renal epithelial cells. J Cell Biol 1991; 114 (1): 53–60.PubMedCrossRefGoogle Scholar
  8. 8.
    Pavo I, Jans DA, Peters R et al. A vasopressin antagonist that binds to the V2-receptor of LLC-PK, renal epithelial cells is highly laterally mobile but does not effect ligand-induced receptor immobilization. Biochim Biophys Acta 1994; 1223: 240–246.PubMedCrossRefGoogle Scholar
  9. 9.
    Schlessinger J. Signal transduction by allosteric receptor oligomerization. Trends Biochem Sci 1988; 13: 443–447.PubMedCrossRefGoogle Scholar
  10. 10.
    Schlessinger J. The epidermal growth factor receptor as a multifunctional allosteric protein. Biochemistry 1989; 27: 3119–3123.CrossRefGoogle Scholar
  11. 11.
    Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990; 61: 203–212.PubMedCrossRefGoogle Scholar
  12. 12.
    Heldin C-H. Structural and functional studies on platelet-derived growth factor. EMBO J 1992; 11: 4251–4259.PubMedGoogle Scholar
  13. 13.
    Panaotou G, Waterfield MD. The assembly of signalling complexes by receptor tyrosine kinases. Bioessays 1993; 15 (3): 171–177.CrossRefGoogle Scholar
  14. 14.
    Tolkovsky AM, Levitzki A. Mode of coupling between the (3-adrenergic receptor and adenylate cyclase in turkey erythrocytes. Biochemistry 1978; 17: 3795–3810.PubMedCrossRefGoogle Scholar
  15. 15.
    Tolkovsky AM, Levitzki A. Coupling of a single adenylate cyclase to two receptors: adenosine and catecholamine. Biochemistry 1978; 17: 3811–3817.PubMedCrossRefGoogle Scholar
  16. 16.
    Tolkovsky A, Braun S, Levitzki A. Kinetics of interaction between 3-receptors, GTP-proteins and the catalytic subunit of turkey erythrocyte adenylate cyclase. Proc Natl Acad Sci USA 1982; 79: 213–217.PubMedCrossRefGoogle Scholar
  17. 17.
    Hanski E, Rimon G, Levitzki A. Adenylate cyclase activation by the 3-adrenergic receptor as a diffusion controlled process. Biochemistry 1979; 18: 846–853.PubMedCrossRefGoogle Scholar
  18. 18.
    Rimon G, Hanski E, Levitzki A. Tempera ture dependence of beta receptor, adenosine receptor, and sodium fluoride stimulated adenylate cyclase from turkey erythrocytes. Biochemistry 1980; 19: 4451–4460.PubMedCrossRefGoogle Scholar
  19. 19.
    Orly J, Schramm M. Fatty acids as modulators of membrane functions; cat-echolamine-activated adenylate cyclase of the turkey erythrocyte. Proc Natl Acad Sci USA 1975; 72: 3433–3437.PubMedCrossRefGoogle Scholar
  20. 20.
    Bergman RN, Hechter H. Neurophyseal hormone-responsive renal adenylate cy-clase IV. A random-hit matrix model for coupling in a hormone-sensitive adeny late cyclase system. J Biol Chem 1978; 253: 3238–3250.PubMedGoogle Scholar
  21. 21.
    Neubig RR, Sklar LA. Subsecond modula tion of formyl peptide-linked guanine nucleotide-binding proteins by guanosine 5’-O-(3-thio)triphosphate in permeabilized neutro phils. Mol Pharmacol 1993; 43 (5): 734–740.PubMedGoogle Scholar
  22. 22.
    Chabre M. The G protein connection: is it in the membrane or the cytoplasm. Trends in Biochem Sci 1987; 12: 213–215.CrossRefGoogle Scholar
  23. 23.
    Helmreich EJM, Elson EL. Protein and lipid mobility. Adv in Cyclic Nucleotide and Prot Phosphor Res 1984; 18: 1–62.Google Scholar
  24. 24.
    Neubig RR, Gantzos RD, Thomsen WJ. Mechanism of agonist and antagonist binding to alpha 2 adrenergic receptors: evidence for a precoupled receptor-guanine nucleotide protein complex. Bio-chemistry 1988; 27 (7): 2374–2384.Google Scholar
  25. 25.
    Gross W, Lohse MJ. Mechanism of activation of A2 adenosine receptors II. A restricted collision-coupling model of receptor-effector interaction. Mol Pharmacol 1991; 39: 524–530.PubMedGoogle Scholar
  26. 26.
    Graeser D, Neubig RR. Compartmentation of receptors and guanine nucleotide-binding proteins in NG108–15 cells: lack of cross-talk nistic in agonist binding among the alpha 2-adr energic, muscarinic, and opiate receptors. Mol Pharmacol 1993; 43 (3): 434–443.PubMedGoogle Scholar
  27. 27.
    Mueller H, Weingarten R, Ransnas LA et al. Differential amplification of antago nistic receptor pathways in neutrophils. J Biol Chem 1991; 266 (20): 12939–12943.PubMedGoogle Scholar
  28. 28.
    Neubig RR, Gantzos RD, Brasier RS. Agonist and antagonist binding to alpha 2-adrenergic receptors in purified mem branes from human platelets. Implications of receptor-inhibitory nucleotide-binding protein stoichiometry. Mol Pharmacol 1985; 28 (5): 475–486.PubMedGoogle Scholar
  29. 29.
    Omann GM, Harter JM, Hassan N et al. A threshold level of coupled G-proteins is required to transduce neutrophil responses. J Immunol 1992; 149 (6): 2172–2178.PubMedGoogle Scholar
  30. 30.
    Moscona-Amir E, Henis YI, Yechiel E et al. Role of lipids in age-related changes in the properties of muscarinic receptor in cultured rat heart myocytes. Biochem-istry 1986; 25 (24): 8118–8124.CrossRefGoogle Scholar
  31. 31.
    Moscona-Amir E, Henis YI, Sololovsky M. Aging of rat heart myocytes disrupts muscarinic receptor coupling that leads to inhibition of cAMP accumulation and alters the pathway of muscarinic-stimu-lated phosphoinositide hydrolysis. Bio-chemistry 1989; 28 (17): 7130–7137.Google Scholar
  32. 32.
    Zakharova OM, Rosenkranz AA, Sobolev AS. Modification of fluid lipid and mo-bile protein fractions of reticulocyte plasma membranes affects agonist-stimu-lated adenylate cyclase. Application of the percolation theory. Biochim Biophys Acta 1995; 1236: 177–184.PubMedCrossRefGoogle Scholar
  33. 33.
    Engelhard VH, Esko JD, Storm DR et al. Modification of adenylate cyclase activ-ity in LM cells by manipulation of the membrane phospholipid composition in vivo. Proc Natl Acad Sci USA 1976; 73: 4482–4486.PubMedCrossRefGoogle Scholar
  34. 34.
    Engelhard VH, Glaser M and Storm DR. Effect of membrane compositional change on adenylate cyclase activity in LM cells. Biochemistry 1978; 17: 3191–3200.PubMedCrossRefGoogle Scholar
  35. 35.
    Brivio-Haugland RP, Louis SL, Musch K et al. Liver plasma membranes from essential farry acid deficient rats: isolation, fatty acid composition and activities of 5’-nucleotidase, ATPase and adenylate cyclase. Biochim Biophys Acta 1976; 433: 150–163.PubMedCrossRefGoogle Scholar
  36. 36.
    Puchwein G, Pfeuffer T, Helmreich EJM. Uncoupling of catecholamine activation of pigeon erythrocyte membrane adeylate cyclase by filipin. J Biol Chem 1974; 249: 3232–3240.PubMedGoogle Scholar
  37. 37.
    Limbird LE, Gill DM, Lefkowitz RJ. Ago-nist-promoted coupling of the (3-adren-ergic receptor with the guanine nucle-otide regulatory protein of the adenylate cyclase system. Proc Natl Acad Sci USA 1980; 77: 775–779.PubMedCrossRefGoogle Scholar
  38. 38.
    Sobolev AS, Rosenkranz AA, Kazarov AR. Interaction of proteins of the adenylate cyclase complex: area-limited mobility of movement along the whole membrane? Analysis with the application of the percolation theory. Biosc Rep 1984; 4: 897–902.CrossRefGoogle Scholar
  39. 39.
    Sobolev AS, Kazarov AR, Rosenkranz AA. Application of percolation theory principles to the analysis of interaction of adenylate cyclase complex proteins in cell membranes. Mol Cell Biochem 1988; 81 (1): 19–28.PubMedCrossRefGoogle Scholar
  40. 40.
    Kazarov AR, Rosenkranz AA, Sobolev AS. Membrane regulation of hormonal activation of adenylate cyclase in rat reticulocyte. Studia Biophysica 1989; 134: 67–71.Google Scholar
  41. 41.
    Bakardjieva A, Gulla HJ, Heimreich EJM. Modulation of the (3-receptor adenylate cyclase interactions in cultured Chang liver cells by phospholipid enrichment. Biochemistry 1979; 18: 3016–3023.PubMedCrossRefGoogle Scholar
  42. 42.
    Shinitzky M, Barenholz Y. Fluidity parameters of lipid regions determined by fluorescence polarization. Biochim Biophys Acta 1978; 515: 367–394.PubMedCrossRefGoogle Scholar
  43. 43.
    Henis YI, Rimon G, Felder S. Lateral mobility of phospholipids in turkey erythrocytes: implications for adenylate cyclase activation. J Biol Chem 1982; 257: 1407–1411.PubMedGoogle Scholar
  44. 44.
    Saxton MJ. The membrane skeleton of erythrocytes. A percolation model. Biophys J 1990; 57: 1167–1177.PubMedCrossRefGoogle Scholar
  45. 45.
    Saxton MJ. The spectrin network as a barrier to lateral diffusion in erythrocytes: a percolation analysis. Biophys J 1989; 55: 21–28.PubMedCrossRefGoogle Scholar
  46. 46.
    Saxton MJ. Lateral diffusion in an archipelago: distance dependence of the diffusion coefficient. Biophys J 1989; 56: 615–622.PubMedCrossRefGoogle Scholar
  47. 47.
    Saxton MJ. Single-particle tracking: effects of corrals. Biophys J 1995; 69 (2): 389–398.PubMedCrossRefGoogle Scholar
  48. 48.
    Atlas D, Volsky DJ, Levitzki A. Lateral mobility of beta-receptors involved in adenylate cyclase activation. Biochim Biophys Acta 1980; 597 (1): 64–69.PubMedCrossRefGoogle Scholar
  49. 49.
    Volsky DJ, Loyter A. Inhibition of membrane fusion by suppression of lateral movement of membrane proteins. Biochim Biophys Acta 1978; 514: 213–224.PubMedCrossRefGoogle Scholar
  50. 50.
    Roess DA, Rahman NA, Kenny N. Molecular dynamics of luteinizing hormone receptors on rat luteal cells. Biochim Biophys Acta 1992; 1137: 309–316.PubMedCrossRefGoogle Scholar
  51. 51.
    Niswender GD, Roess DA, Sawyer HR et al. Differences in the lateral mobility of receptors for luteinizing hormone (LH) in the luteal plasma membrane when occupied by ovine LH versus human chorionic gonadotropin. Endocrinol 1985; 116: 164–169.CrossRefGoogle Scholar
  52. 52.
    Roess DA, Niswender GD, Barisas BG. Cytocholasins and colchicine increase the lateral mobility of human chorionic gonadotropin-occupied luteinizing hormone receptors on ovine luteal cells. Endocrinol 1988; 122: 261–269.CrossRefGoogle Scholar
  53. 53.
    Jacobson K, O’Dell D, August JT. Lateral diffusion of an 80,000-dalton glycoprotein in the plasma membrane of murine fibroblasts: relationships to cell structure and function. J Cell Biol 1984; 99 (5): 1624–1633.PubMedCrossRefGoogle Scholar
  54. 54.
    Duband J-L, Nuckolls GH, Ishihara A et al. Fibronectin receptor exhibits high lateral mobility in embryonic locomoting cells but is immobile in focal contacts and fibrillar streaks in stationary cells. J Cell Biol 1988; 107: 1385–1396.PubMedCrossRefGoogle Scholar
  55. 55.
    Roettger BF, Rentsch RU, Hadac EM et al. Insulation of a G protein-coupled receptor on the plasmalemmal surface of the pancreatic acinar cell. J Cell Biol 1995; 130: 579–590.PubMedCrossRefGoogle Scholar
  56. 56.
    Johansson B, Wymann MP, HolmgrenPeterson K et al. N-formyl peptide receptors in human neutrophils display distinct membrane distribution and lateral mobility when labeled with agonist and antagonist. J Cell Biol 1993; 121: 1281–1289.PubMedCrossRefGoogle Scholar
  57. 57.
    Zidovetzki R, Yarden Y, Schlessinger, J et al. Rotational diffusion of epidermal growth factor complexed to its surface receptor the rapid microaggregation and endocytosis of occupied receptors. Proc Nati Acad Sci USA 1981; 78: 6981–6985.CrossRefGoogle Scholar
  58. 58.
    Hillman GM, Schlessinger J. The lateral diffusion of epidermal growth factor complexed to its surface receptors does not account for the thermal sensitivity of patch formation and endocytosis. Biochemistry 1982; 21: 1667–1672.PubMedCrossRefGoogle Scholar
  59. 59.
    Fire E, Zwart DE, Roth MG et al. Evidence from lateral mobility studies for dynamic interactions of a mutant influenza hemagglutinin with coated pits. J Cell Biol 1991; 115: 1585–1594.PubMedCrossRefGoogle Scholar
  60. 60.
    Jans DA, Resink TJ, Wilson E-L et al. Isolation of a mutant LLC-PK, cell line defective in hormonal responsiveness: a pleiotropic lesion affecting receptor function. Eur J Biochem 1986; 160: 407–412.PubMedCrossRefGoogle Scholar
  61. 61.
    Jans DA, Resink TJ, Hemmings BA. Complementation between LLC-PK1 mutants affected in polypeptide hormone receptor function. Eur J Biochem 1987; 162: 571–576.PubMedCrossRefGoogle Scholar
  62. 62.
    Luzius H, Jans DA, Jans P et al. Isolation and genetic characterization of a renal epithelial cell mutant defective in vasopressin V,-type receptor binding and function. Exper Cell Res 1991; 195: 478–484.CrossRefGoogle Scholar
  63. 63.
    Briggs MM, Lefkowitz RJ. Parallel modulation of catecholamine activation of adenylate cyclase and formation of the high-affinity agonist receptor complex in turkey erythrocyte membranes by temperature and cis-vaccenic acid. Biochemistry 1980; 19: 4461–4466.PubMedCrossRefGoogle Scholar
  64. 64.
    Golan DE, Veatch W. Lateral mobility of band 3 in the human erythrocyte membrane studied by fluorescence photobleaching recovery: evidence for control by cytoskeletal interactions. Proc Natl Acad Sci USA 1980; 77: 2537–2541.PubMedCrossRefGoogle Scholar
  65. 65.
    Tsuji A, Ohnishi S. Restriction of the lateral motion of Band 3 in the erythrocyte membrane by the cytoskeletal network: dependence on spectrin association state. Biochemistry 1986; 25: 6133–6139.PubMedCrossRefGoogle Scholar
  66. 66.
    Jacobson K, O’Dell D, August JT. Lateral diffusion of an 80,000-dalton glycoprotein in the plasma membrane of murine fibroblasts: relationships to cell structure and function. J Cell Biol 1984; 99 (5): 1624–1633.PubMedCrossRefGoogle Scholar
  67. 67.
    Palter MS. Lateral mobility of Na,K-ATPase and membrane lipids in renal cells. Importance of cytoskeletal integrity. J Membr Biol 1994; 142 (1): 127–135.Google Scholar
  68. 68.
    Smith PR, Stoner JC, Viggiano SC et al. Effects of vasopressin and aldosterone on the lateral mobility of eptihelial Na’ channels in A6 epithelial cells. J Memb Biol 1995; 147 (2): 195–205.CrossRefGoogle Scholar
  69. 69.
    Gupte SS. Localization and diffusion of glucagon receptor in rat hepatocytes. Receptor 1994; 4 (3): 175–190.PubMedGoogle Scholar
  70. 70.
    Braun S, Levitzki A. The attenuation of epinephrine-dependent adenylate cyclase by adenosine and the characteristics of the adenosine stimulatory and inhibitory sites. Mol Pharmacol 1979; 16: 737–748.PubMedGoogle Scholar
  71. 71.
    Ransnäs LA, Insel PA. Subunit dissociation is the mechanism for hormonal activation of the G, protein in native membranes. J Biol Chem 1988; 263: 17239–17242.PubMedGoogle Scholar
  72. 72.
    Ransnäs LA, Svoboda P. Jasper JR et al. Stimulation of 3-receptors of S49 lymphoma cells redistributes the subunit of the stimulatory G protein between cytosol and membranes. Proc Natl Acad Sci USA 1989; 86: 7900–7903.PubMedCrossRefGoogle Scholar
  73. 73.
    Bokoch GM, Bickford K, Bohl BP. Sub-cellular localization and quantitation of the major neutrophil pertussis toxin substrate, Gn. J Cell Biol 1988; 106(6):1927–1936.CrossRefGoogle Scholar
  74. 74.
    Lynch CJ, Morbach L, Blackmore PF et al. a-subunits of N, are released from the plasma membrane following cholera toxin activation. FEBS Lett. 1986; 200: 333–336.PubMedCrossRefGoogle Scholar
  75. 75.
    Deckmyn H, Tu SM, Majerus PW. Guanine nucleotides stimulate soluble phosphoinositide-specific phospholipase C in the absence of membranes. J Biol Chem 1986; 261 (35): 16553–16558.PubMedGoogle Scholar
  76. 76.
    Molina Y, Vedia L, Lapetina EG. Iloprost-induced translocation of a 23-kDa protein that is recognized by a Gsa antiserum. Proc Natl Acad Sci USA 1989; 86 (3): 868–870.CrossRefGoogle Scholar
  77. 77.
    Zamorski MA, Ferraro JC, Neubig RR. Subcellular distribution of a2-adrenergic receptors, pertussis-toxin substrate and adenylate cyclase in human platelets. Biochem J 1990; 265 (3): 755–762.PubMedGoogle Scholar
  78. 78.
    McArdle H, Mullaney I, Magel A et al. GTP analogues cause release of the a subunit of the GTP binding protein, Go, from the plasma membrane of NG10815 cells. Biochem Biophys Res Commun 1988; 152: 243–251.PubMedCrossRefGoogle Scholar
  79. 79.
    Negishi M, Hashimoto H, Ichikawa A. Translocation of a subunits of stimula-tory guanine nucleotide-binding proteins through stimulation of the prostacyclin receptor in mouse mastocytoma cells. J Biol Chem 1992; 267: 2364–2369.PubMedGoogle Scholar
  80. 80.
    Stryer L, Bourne HR. G proteins: a family of signal transducers. Annu Rev Cell Biol 1986; 2: 391–419.PubMedCrossRefGoogle Scholar
  81. 81.
    Remmers AE, Neubig RR. Resonance energy transfer between guanine nucleotide binding protein subunits and membrane lipids. Biochemistry 1993; 32 (9): 2409–2414.PubMedCrossRefGoogle Scholar
  82. 82.
    Peters R. Fluorescence microphotolysis to measure nucleocytoplasmic transport and intracellular mobility. Biochim Biophys Acta 1986; 864: 305–359.PubMedCrossRefGoogle Scholar
  83. 83.
    Clapham DE, Neer EJ. New roles for G-protein fry-dimers in transmembrane signalling. Nature 1993; 365: 403–406.PubMedCrossRefGoogle Scholar
  84. 84.
    Bourne HR, Sanders DA, McCormick F. The GTPase superfamily: conserved structure and molecular mechanism. Nature 1991; 349: 117–127.PubMedCrossRefGoogle Scholar
  85. 85.
    Spiegel AM, Shenker A, Weinstein LS. Receptor-effector coupling by G proteins: implications for normal and abnormal signal transduction. Endocrine Rev 1992; 13: 536–565.Google Scholar
  86. 86.
    Conklin BR, Bourne HR. Structural elements of Ga subunits that interact with Gßy, receptors, and effectors. Cell 1993; 73: 631–641.PubMedCrossRefGoogle Scholar
  87. 87.
    Tang WJ, Gilman AG. Type-specific regulation of adenylyl cyclase by G protein (3y subunits. Science 1991; 254 (5037): 1500–1503.PubMedCrossRefGoogle Scholar
  88. 88.
    Warner DR, Basi NS, Rebois RV. Cell-free synthesis of functional type IV adenylyl cyclase. Anal Biochem 1995; 232 (1): 31–36.PubMedCrossRefGoogle Scholar
  89. 89.
    Logothetis DE, Kurachi Y, Galper J et al. The ßy subunits of GTP-binding proteins activate the muscarinic K* channel in heart. Nature 1987; 325: 321–326.PubMedCrossRefGoogle Scholar
  90. 90.
    Codina J, Yatani A, Grenet D et al. The a-subunit of the GTP binding protein Gk opens atrial potassium channels. Science 1987; 236: 536–538.CrossRefGoogle Scholar
  91. 91.
    Krapivinsky G, Krapivinsky L, Wickman K et al. Gßy binds directly to the G protein-gated K+ channel, IKACh. J Biol Chem 1995; 270 (49): 29059–29062.PubMedCrossRefGoogle Scholar
  92. 92.
    Schreibmayer W, Dessauer CW, Vorobiov D et al. Inhibition of an inwardly rectifying K+ channel by G-pro-tein a-subunits. Nature 1996; 380 (6575): 624–627.PubMedCrossRefGoogle Scholar
  93. 93.
    Jelsema CL, Axelrod J. Stimulation of phospholipase A2 activity in bovine rod outer segments by the (3y subunits of transducin and its inhibition by the a subunit. Proc Natl Acad Sci USA 1987; 84 (11): 3623–3627.PubMedCrossRefGoogle Scholar
  94. 94.
    Katz A, Wu D, Simon MI. Subunits 13y of heterotrimeric G protein activate G32 isoform of phospholipase C. Nature 1992; 360: 686–689.PubMedCrossRefGoogle Scholar
  95. 95.
    Leberer E, Dignard D, Hougan L et al. Dominant-negative mutants of a yeast G-protein 3 subunit identify two functional regions involved in pheromone signalling. EMBO J 1992; 11 (13): 4805–4813.PubMedGoogle Scholar
  96. 96.
    Leberer E, Dignard D, Harcus D et al. The protein kinase homologue Ste20p is required to link the yeast pheromone response G-protein (3y subunits to downstream signalling components. EMBO J 1992; 11 (13): 4815–4824.PubMedGoogle Scholar
  97. 97.
    Haga K, Haga T. Activation by G protein fry subunits of agonist-or light-dependent phosphorylation of muscarinic acetylcholine receptors and rhodopsin. J Biol Chem 1992; 267 (4): 2222–2227.PubMedGoogle Scholar
  98. 98.
    Kameyama K, Haga K, Haga T et al. Activation by G protein 13y subunits of 3-adrenergic and muscarinic receptor kinase. J Biol Chem 1993; 268 (11): 7753–7758.PubMedGoogle Scholar
  99. 99.
    Haga K, Kameyama K, Haga T. Synergistic activation of a G protein-coupled receptor kinase by G protein fry subunits and mastoparan or related peptides. J Biol Chem 1994; 269 (17): 12594–12599.PubMedGoogle Scholar
  100. 100.
    Haga T, Haga K, Kameyama K et al. Phosphorylation of muscarinic receptors: regulation by G proteins. Life Sci 1993; 52 (5–6): 421–428.PubMedCrossRefGoogle Scholar
  101. 101.
    Inglese J, Koch WJ, Caron MG. Isoprenylation in regulation of signal transduction by G-protein-coupled receptor kinases. Nature 1992; 359 (6391): 147–150.PubMedCrossRefGoogle Scholar
  102. 102.
    Pitcher JA, Inglese J, Higgins JB et al. Role of fry subunits of G proteins in targeting the (3-adrenergic receptor kinase to membrane-bound receptors. Science 1992; 257 (5074): 1264–1267.PubMedCrossRefGoogle Scholar
  103. 103.
    Alousi AA, Jasper JR, Insel PA et al. Stoichiometry of receptor-Gs-adenylate cyclase interactions. FASEB J 1991; 5: 2300–2303.PubMedGoogle Scholar
  104. 104.
    Dratz EA, Miljanich GP, Nemes PP et al. The structure of rhodopsin and its disposition in the rod outer segment disk membrane. Photochem Photobiol 1979; 29 (4): 661–670.PubMedCrossRefGoogle Scholar
  105. 105.
    Lamb TD. Stochastic simulation of activation in the G-protein cascade of phototransduction. Biophys J 1994; 67: 1439–1454.PubMedCrossRefGoogle Scholar
  106. 106.
    Hamm HE, Bownds MD. Protein complement of rod outer segments of frog retina. Biochemistry 1986; 25 (16): 4512–4523.PubMedCrossRefGoogle Scholar
  107. 107.
    Dumke CL, Arshaysky VY, Calvert PD et al. Rod outer segment structure influences the apparent kinetic parameters of cyclic GMP phosphodiesterase. J Gen Physiol 1994; 103 (6): 1071–1098.PubMedCrossRefGoogle Scholar
  108. 108.
    Braun S, Levitzki A. Adenosine receptor permanently coupled to turkey erythrocyte adenylate cyclase. Biochemistry 1979; 18: 2134–2138.PubMedCrossRefGoogle Scholar
  109. 109.
    Lohse MJ, Klotz KN, Schwabe U. Mechanism of A2 adenosine receptor activation. I. Blockade of A2 adenosine receptors by photoaffinity labeling. Mol Pharmacol 1991; 39: 517–523.PubMedGoogle Scholar
  110. 110.
    Kwon G, Axelrod D, Neubig RR. Lateral mobility of tetramethylrhodamine (TMR) labelled G protein alpha and beta gamma subunits in NG 108–15 cells. Cell Signal 1994; 6 (6): 663–679.PubMedCrossRefGoogle Scholar
  111. 111.
    Neubig RR. Membrane organization in G-protein mechanisms. FASEB J 1994; 8: 939–946.PubMedGoogle Scholar
  112. 112.
    Sarndahl E, Bokoch GM, Stendahl O et al. Stimulus-induced dissociation of alpha subunits of heterotrimeric GTPbinding proteins from the cytoskeleton of human neutrophils. Proc Natl Acad Sci USA 1993; 90: 6552–6556.PubMedCrossRefGoogle Scholar
  113. 113.
    Leiber D, Jasper JR, Alousi AA et al. Alteration in Gs-mediated signal transduction in S49 lymphoma cells treated with inhibitors of microtubules. J Biol Chem 1993; 268: 3833–3837.PubMedGoogle Scholar
  114. 114.
    Rasenick MM, Wang N. Exchange of guanine nucleotides between tubulin and GTP-binding proteins that regulate adenylate cyclase: cytoskeletal modification of neuronal signal transduction. J Neurochem 1988; 51: 300–311.PubMedCrossRefGoogle Scholar
  115. 115.
    Rasenick MM, Wang N, Yan K. Specific associations between tubulin and G pro-teins: participation of cytoskeletal elements in cellular signal transduction. Adv Second Messenger Phosphoprot Res 1990; 24: 381–386.Google Scholar
  116. 116.
    Wang N, Rasenick MM. Tubulin-G protein interactions involve microtubule polymerization domains. Biochemistry 1991; 30: 10957–10965.PubMedCrossRefGoogle Scholar
  117. 117.
    Bourguignon LYW, Walker G, Huang HS. Interactions between a lymphoma membrane-associated guanosine 5’-triphosphatebinding protein and the cytoskeleton during receptor patching and capping. J Immunol 1990; 144: 2242–2252.PubMedGoogle Scholar
  118. 118.
    Carlson KE, Woolkalis MJ, Newhouse MG et al. Fractionation of the beta subunit common to guanine nucleotide-binding regulatory proteins with the cytoskeleton. Mol Pharmacol 1986; 30: 463–468.PubMedGoogle Scholar
  119. 119.
    Macias MJ, Musacchio A, Ponstingl H et al. Structure of the pleckstrin homology domain from beta-spectrin. Nature 1994; 369: 675–677.PubMedCrossRefGoogle Scholar
  120. 120.
    Lombardo CR, Weed SA, Kennedy SP et al. Beta II-spectrin(fodrin) and beta I epsilon 2spectrin (muscle) contain NH2- and COOH-terminal membrane association domains (MAD1 and MAD2). J Biol Chem 1994; 269 (46): 29212–29219.PubMedGoogle Scholar
  121. 121.
    Musacchio A, Gibson T, Rice P et al. The PH domain: a common piece in the structural patchwork of signalling proteins. Trends Biochem Sci 1993; 18 (9): 343–348.PubMedCrossRefGoogle Scholar
  122. 122.
    Shaw G. Identification of novel pleckstrin homology (PH) domains provides a hypothesis for PH domain function. Biochem Biophys Res Commun 1993; 195 (2): 1145–1151.PubMedCrossRefGoogle Scholar
  123. 123.
    Brandt DR, Ross EM. Catecholamine-stimulated GTPase cycle; multiple sites of regulation by 3-adrenergic receptor and Mg-’ studied in reconstituted receptor-G, vesicles. J Biol Chem 1986; 261: 1656–1664.PubMedGoogle Scholar
  124. 124.
    Ciccarelli-E, Svoboda-M, Neef-P et al. Pharmacological properties of two recombinant splice variants of the PACAP type I receptor, transfected and stably expressed in CHO cells. Eur J Pharmacol 1995; 288 (3): 259–267.PubMedCrossRefGoogle Scholar
  125. 125.
    Baylor D. How photons start vision. Proc Natl Acad Sci USA 1996; 93 (2): 560–565.PubMedCrossRefGoogle Scholar
  126. 126.
    Nanoff C, Mitterauer T, Roka F et al. Species differences in Al adenosine receptor/G protein coupling: identification of a membrane protein that stabilizes the association of the receptor/G protein complex. Mol Pharmacol 1995; 48 (5): 806–817.PubMedGoogle Scholar
  127. 127.
    Marcil J, Anand-Srivastava MB. Defective ANF-R2/ANP-C receptor-mediated signalling in hypertension. Mol Cell Biochem 1995; 149–150: 223–231.CrossRefGoogle Scholar
  128. 128.
    Carroll RC, Morielli AD, Peralta EG. Coincidence detection at the level of phospholipase C activation mediated by the m4 muscarinic acetylcholine receptor. Curr Biol 1995; 5 (5): 536–544.PubMedCrossRefGoogle Scholar
  129. 129.
    Schlegel W, Kempner ES, Rodbell M. Activation of adenylate cyclase in hepatic membranes involves interactions of the catalytic unit with multimeric complexes of regulatory proteins. J Biol Chem 1979; 254 (12): 5168–5176.PubMedGoogle Scholar
  130. 130.
    Rodbell M. The role of GTP-binding proteins in signal transduction: from the sublimely simple to the conceptually complex. Curr Top Cell Regul 1992; 32: 1–47.PubMedGoogle Scholar
  131. 131.
    Nakamura S, Rodbell M. Glucagon induces disaggregation of polymer-like structures of the a-subunit of the stimulatory G protein in liver membranes. Proc Natl Acad Sci USA 1991; 88 (16): 7150–7154.PubMedCrossRefGoogle Scholar
  132. 132.
    Nakamura S, Rodbell M. Octyl glucoside extracts GTP-binding regulatory proteins from rat brain “synaptoneurosomes” as large, polydisperse structures devoid of beta gamma complexes and sensitive to disaggregation by guanine nucleotides. Proc Natl Acad Sci USA 1990; 87 (16): 6413–6417.PubMedCrossRefGoogle Scholar

Copyright information

© R.G. Landes Company 1997

Authors and Affiliations

  • David A. Jans
    • 1
  1. 1.John Curtin School of Medical ResearchAustralian National UniversityCanberraAustralia

Personalised recommendations